Procter & Gamble (NYSE:PG) Shares Sold by Rep. David Taylor

Key Points

• Rep. David Taylor sold $1,001–$15,000 of Procter & Gamble shares on October 12, following a purchase of the stock in September. He also recently bought shares of Fifth Third Bancorp, RPM International and AT&T.
• Procter & Gamble reported quarterly EPS of $1.43, slightly ahead of estimates, while revenue rose 1.5% year over year to $21.20 billion. The company declared a quarterly dividend of $1.0885, representing a 2.7% annualized yield.
• Analysts maintain a generally positive view, with a consensus rating of “Moderate Buy” and an average price target of $162.20. Upcoming earnings on October 22 will focus on sales momentum, margins, volumes and updated guidance.

Representative David Taylor (Republican-Ohio) recently sold shares of Procter & Gamble Company (The) (NYSE:PG). In a filing disclosed on October 15th, the Representative disclosed that they had sold between $1,001 and $15,000 in Procter & Gamble stock on October 12th. The trade occurred in the Representative's "DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)" account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Fifth Third Bancorp NASDAQ: FITB on 10/9/2026.
• Purchased $1,001 - $15,000 in shares of RPM International NYSE: RPM on 10/9/2026.
• Purchased $1,001 - $15,000 in shares of AT&T NYSE: T on 10/9/2026.
• Sold $1,001 - $15,000 in shares of Marathon Petroleum NYSE: MPC on 9/22/2026.
• Purchased $1,001 - $15,000 in shares of Home Depot NYSE: HD on 9/22/2026.
• Purchased $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 9/22/2026.
• Purchased $1,001 - $15,000 in shares of Installed Building Products NYSE: IBP on 9/8/2026.
• Purchased $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 9/8/2026.
• Sold $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 8/26/2026.
• Sold $1,001 - $15,000 in shares of Vertex Pharmaceuticals NASDAQ: VRTX on 8/26/2026.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $159.25 on Friday. The firm's 50 day moving average price is $146.88 and its 200-day moving average price is $146.52. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $167.25. The company has a quick ratio of 0.47, a current ratio of 0.68 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $369.89 billion, a PE ratio of 22.80, a price-to-earnings-growth ratio of 3.90 and a beta of 0.39.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.41 by $0.02. The business had revenue of $21.20 billion during the quarter, compared to analysts' expectations of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm's revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the company earned $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities research analysts expect that Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 23rd. Procter & Gamble's dividend payout ratio (DPR) is 65.71%.

Analyst Ratings Changes

PG has been the subject of several recent research reports. BMO Capital Markets boosted their price target on Procter & Gamble from $169.00 to $170.00 and gave the company an "outperform" rating in a report on Monday, June 29th. Barclays upped their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 21st. TD Cowen reaffirmed a "hold" rating and issued a $150.00 price objective on shares of Procter & Gamble in a research note on Wednesday, September 30th. HSBC reaffirmed a "hold" rating and set a $149.00 price objective (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Procter & Gamble in a research note on Monday, September 21st. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average price target of $162.20.

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Improving U.S. sales outlook: UBS maintained its Buy rating and $172 price target, saying better U.S. sales momentum could help P&G outperform expectations when it reports before the market opens on October 22. Procter & Gamble's improving US sales trends set up a favorable first-quarter report, UBS says
• Positive Sentiment: Defensive dividend appeal: Recent investor-focused coverage highlighted P&G’s 70-year record of dividend increases. That long history, combined with demand for everyday household products, may support the stock as investors seek stable income and less exposure to technology-sector volatility. Procter & Gamble Has Raised Its Dividend for 70 Years
• Neutral Sentiment: Upcoming earnings are the key catalyst: Analysts expect modest revenue growth for fiscal first-quarter 2027, while the company’s latest reported quarter showed revenue growth of 1.5% year over year and earnings that narrowly exceeded consensus. Investors will focus on organic sales, pricing, volumes and updated full-year guidance. Procter & Gamble Set to Release Earnings
• Negative Sentiment: Profit risks remain: Earnings previews warn that rising costs could pressure margins and cause quarterly earnings to decline, reducing the likelihood of a significant earnings beat. P&G’s valuation—about 24 times earnings based on the supplied data—also leaves less room for disappointment. Procter & Gamble Pre-Q1 Earnings
• Negative Sentiment: Some institutional selling: ETFs were reported as net sellers of PG, a modest near-term technical headwind, though this flow does not necessarily signal a change in the company’s long-term fundamentals. ETFs Are Net Sellers of Procter & Gamble

Insider Transactions at Procter & Gamble

In related news, insider Marc Pritchard sold 4,030 shares of the company's stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the completion of the sale, the insider directly owned 187,001 shares of the company's stock, valued at $26,888,873.79. This represents a 2.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50. Following the transaction, the chief executive officer owned 51,124 shares in the company, valued at approximately $7,430,362.16. The trade was a 4.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 15,135 shares of company stock valued at $2,189,970 over the last three months. 0.23% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Procter & Gamble

Several hedge funds and other institutional investors have recently made changes to their positions in PG. James T. Borello RIA purchased a new stake in shares of Procter & Gamble in the third quarter valued at approximately $96,000. V Square Quantitative Management LLC grew its position in shares of Procter & Gamble by 5.4% during the 3rd quarter. V Square Quantitative Management LLC now owns 52,286 shares of the company's stock worth $7,596,000 after buying an additional 2,663 shares in the last quarter. YANKCOM Partnership increased its stake in shares of Procter & Gamble by 9.4% during the third quarter. YANKCOM Partnership now owns 13,540 shares of the company's stock valued at $1,967,000 after buying an additional 1,163 shares during the period. Financial & Tax Architects LLC increased its stake in shares of Procter & Gamble by 4.1% during the third quarter. Financial & Tax Architects LLC now owns 50,341 shares of the company's stock valued at $7,314,000 after buying an additional 1,969 shares during the period. Finally, Comprehensive Financial Consultants Institutional Inc. raised its holdings in shares of Procter & Gamble by 3.4% in the third quarter. Comprehensive Financial Consultants Institutional Inc. now owns 11,361 shares of the company's stock valued at $1,651,000 after acquiring an additional 375 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company's stock.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio's 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Taylor (Republican Party) ran for election to the U.S. House to represent Ohio's 2nd Congressional District. He won in the general election on November 5, 2024. David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor's career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

Procter & Gamble Company Profile

The Procter & Gamble Company NYSE: PG is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.

Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.

Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.